A "hot" tumor, characterized by a heavy infiltration of T cells, may be more likely to respond to PD-1/PD-L1 blockade than a "cold" tumor with fewer immune cells present (Huang et al., 2021[36]). Here, PDCD1 is linked to neoplasm.